EMCURE.NS Profit & Loss
Emcure Pharmaceuticals Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 2 years on file
(FY2024-25 to FY2025-26)
· fetched 2026-08-24 01:34
| Line item | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|
| Revenue from Operations | ₹7,896.00 Cr. | ₹9,203.54 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹67.26 Cr. | ₹12.66 Cr. | OtherIncome |
| Total Income | ₹7,963.26 Cr. | ₹9,216.20 Cr. | Income |
| Cost of Materials Consumed | ₹1,526.90 Cr. | ₹1,692.77 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹1,883.23 Cr. | ₹2,397.25 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-263.53 Cr. | ₹-432.96 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹1,446.29 Cr. | ₹1,552.20 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹175.78 Cr. | ₹143.67 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹384.13 Cr. | ₹415.05 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹1,828.72 Cr. | ₹2,129.73 Cr. | OtherExpenses |
| Total Expenses | ₹6,981.53 Cr. | ₹7,897.71 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹981.73 Cr. | ₹1,318.49 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹-10.38 Cr. | ₹-31.35 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹971.35 Cr. | ₹1,287.14 Cr. | ProfitBeforeTax |
| Tax Expense | ₹263.88 Cr. | ₹345.87 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹707.47 Cr. | ₹941.27 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹681.33 Cr. | ₹924.36 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹36.43 | ₹48.77 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹36.43 | ₹48.77 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from EMCURE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).